Access cutting-edge scleroderma treatment through this clinical trial at a research site in Birmingham. Study-provided care at no cost to qualified participants.
Access scleroderma specialists in Birmingham at no cost
This study follows strict safety protocols and ethical guidelines
All study-related scleroderma treatment provided free
The goal of this clinical trial is to test efficacy of different investigational products (IPs) compared with placebo on the change from baseline to the end of the treatment period at Week 52 in lung capacity in participants with Interstitial Lung Disease Secondary to Systemic Sclerosis.
Sponsor: Scleroderma Research Foundation, Inc.
Check if you qualify for this scleroderma clinical trial in Birmingham, AL
If you're searching for scleroderma treatment options in Birmingham, AL, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Birmingham research site is actively enrolling participants for this clinical trial. You'll receive care from experienced scleroderma specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.